NASDAQ WELCOMES NATTOPHARMA TO NASDAQ FIRST NORTH

Stockholm, May 18, 2015 — Nasdaq (Nasdaq: NDAQ) announces that the trading in NattoPharma ASA’s shares (short name: NATTO) commenced today on Nasdaq First North in Stockholm. NattoPharma belongs to the Consumer Goods sector and is the 33^rd company to be admitted to trading on Nasdaq’s Nordic markets* in 2015. NattoPharma is also listed on Oslo Axess.

NattoPharma® is a worldwide innovator and pioneer of Vitamin K2, Menaquinone-7(MK-7). The company’s brand MenaQ7® is supported by a global IPR portfolio and research substantiating clear efficacy for bone and cardiovascular health. For more information, please visit www.nattopharma.com.

“NattoPharma is aware that the interest and knowledge about biotechnology and pharmaceutical product development is huge in Sweden, which is one of the reasons behind our decision to enter Nasdaq First North,” said Hogne Vik, CEO of NattoPharma. “We have great expectations of both our investor visibility at Nasdaq and the expected increased trading activity within the NattoPharma share.” 

“We welcome NattoPharma to Nasdaq First North and to our family of companies,” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “NattoPharma’s dual listing at Nasdaq First North is a testament to the strong liquidity and investor exposure that we can offer our listed companies.”

NattoPharma has appointed Avanza Bank AB as Certified Adviser.

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.

About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $9.5 trillion and more than 10,000 corporate clients. To learn more, visit nasdaq.com/ambition or business.nasdaq.com.

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.